Business Standard

Jubilant Life Sciences receives revision in credit ratings from CRISIL

Image

Capital Market
Jubilant Life Sciences announced that CRISIL has assigned the following ratings to the company's facilities -

Long term rating for bank loan facilities (Rs 510 crore) - CRISIL AA (Placed on 'Rating Watch with Developing Implications')

Non-Convertible Debentures (Rs 350 crore) - CRISIL AA (Continues on 'Rating Watch with Developing Implications') (Rating withdrawn as NCDs have been fully redeemed)

Commercial Paper Programme (Rs 400 crore) - CRISIL A1+ (Reaffirmed)

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 10 2020 | 12:17 PM IST

Explore News